The Endocannabinoid System and Potential Therapeutic Uses in Multiple Sclerosis and other Neuroinflammatory Diseases

Multiple sclerosis is the most common inflammatory demyelinating disease of the central nervous system, caused by an autoimmune response against myelin that eventually leads to progressive neurodegeneration and disability. Although the knowledge on its underlying neurobiological mechanisms has considerably improved, there is a still unmet need for new treatment options,

Read more

Effectiveness of Medical Cannabis for Parkinson’s Disease

Medical Cannabis for Parkinson's
Current treatments of Parkinson disease (PD) and parkinsonism still provide suboptimal effects, especially regarding the patients’ quality of life. This has led to the search for alternative and often unconventional therapies, such as medical cannabis for Parkinson’s Disease (PD). The use of medical cannabis (MC) is controversial. Support for its

Read more